$901.372M Market Capitalization Mind Medicine Inc. (MNMD.Q) today announced the initiation of a Phase 2a proof-of-concept (POC) trial of lysergic acid diethylamide (LSD) in adult patients with attention deficit…
children
Nowhere is the difference between the generations more stark than in how we raise our children. My generation are the original latchkey kids—our parents had to work stupid hours…
The scene: Late 2005, a run down pharmacy in East Vancouver. It’s early on a Sunday morning, raining heavily outside, and I haven’t slept for three days other than…